Table 2.
Trial activities | Before COVID-19 | Revised in response to COVID-19 |
Trial assessments |
Clinic appointments Phone calls |
Telehealth appointments Phone calls |
Consent | Clinic appointments |
Telehealth appointments Phone calls and verbal consent Post/email consent forms |
Patient surveys |
Paper survey Email survey Electronic device |
Phone calls Post/email survey |
Investigational product | Hospital pharmacy dispensing | Home delivery |
Training |
On-site initiation meetings Videoconference |
Videoconference Videoconference recordings available on demand |
Meetings |
Face to face Videoconference |
Videoconference |
Monitoring activities | Before COVID-19 | Revised in response to COVID-19 |
Informed consent process | On-site visits |
Remote monitoring visit phone calls Additional training and resources |
Source data verification | On-site visits |
Remote electronic medical record access Review administrative data sets |
Data quality/trends | Remote data monitoring |
Remote monitoring phone calls Remote data monitoring: - Focus on safety and outcome data - Data entry and query resolution timeframes relaxed during the peak of COVID-19 - Check COVID-19 protocol deviations |
Essential document checks |
On-site visits Electronic Trial Master File platform (limited use) |
Written confirmation Electronic Trial Master File platform (wider use planned) |
Monitoring checklists | On-site visit checklist | Remote monitoring visit phone call checklists |